Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
1.048 Leser
Artikel bewerten:
(2)

New to The Street Episode #678 to Air on Bloomberg TV Featuring Game-Changing Innovators in AI, Biotech, Blockchain, and Sustainability

Broadcast Premieres Saturday, July 12 at 6:30 PM EST on Bloomberg Television

NEW YORK CITY, NY / ACCESS Newswire / July 12, 2025 / New to The Street, the leading multi-platform financial news series, announces its upcoming Bloomberg Television broadcast, airing Saturday, July 12 at 6:30 PM EST. Episode #678 showcases five transformative companies leading advancements across artificial intelligence, healthcare, sustainability, and blockchain. This dynamic lineup brings powerful insights from visionary leaders shaping the future of their respective industries.

Featured Segments in Episode #678:

Hapbee Technologies (OTCQB:HAPBF)
NBA All-Star Jaylen Brown shares how Hapbee's groundbreaking wearable neurotech helps optimize sleep, recovery, and cognitive performance-without pharmaceuticals. The device uses proprietary low-frequency signals to emulate the effects of popular compounds, empowering users to choose how they feel, naturally and safely.

Arrive AI (NASDAQ:ARAI)
Live from Nasdaq MarketSite in Times Square, host Ana Berry interviews CEO Dan O'Toole and Chief Strategy Officer Neerav Shah as they unveil Arrive's secure smart mailbox technology. Phase 1 launches in healthcare and logistics; Phase 2 expands to every U.S. ZIP code. Arrive beat Amazon to the patent by four days, reinforcing its first-mover advantage in the $150B+ last-mile delivery sector.

FLOKI (CRYPTO:FLOKI)
Pedro Vidal, FLOKI's Community Relations Officer, discusses the explosive success of Valhalla, its play-to-earn metaverse game. As FLOKI expands across DeFi, NFTs, and blockchain gaming, its highly engaged global community cements it as one of crypto's most disruptive and culturally relevant brands. Learn more at www.floki.com.

BioVie Inc. (NASDAQ:BIVI)
CEO Cuong Do and Chief Medical Officer Joseph Palumbo join Jane King to share meaningful updates on BioVie's advancement in clinical trials targeting Alzheimer's, Parkinson's, and Long COVID. BioVie is the only company to receive a federal grant to study Long COVID, and is currently enrolling patients in a 200-person clinical trial. They also introduce Social Impact Partners, a nonprofit initiative to foster collaboration across the private, public, and government sectors in supporting Alzheimer's patients. The segment touches on promising new research around BioVie's investigational drug Bezisterim, which may reduce cellular "rust buildup"-a key contributor to aging. Initial findings suggest it could play a role in slowing the aging process.

The Sustainable Green Team (OTC:SGTM)
CEO Tony Raynor outlines how SGTM transforms organic landfill waste into premium garden and soil products. What began as a mulch and tree removal business is now a regenerative brand with Amazon-ready offerings and national retail ambitions. SGTM is on a mission to restore soil health across America. Learn more at www.SGTMTech.com.

This episode is presented as sponsored programming on Bloomberg Television, reaching more than 124 million households nationwide. Further distribution includes:

  • New to The Street's YouTube channel with 3 million+ subscribers

  • Earned media coverage across major networks

  • Iconic outdoor billboards in Times Square and major U.S. metros

Sponsors for Episode #678 include MUSQ, IPOMarket.com, and Arrive AI TV Commercials.

"We're proud to deliver this high-impact episode featuring leaders from five of the most innovative sectors," said Vince Caruso, Co-Founder and Executive Producer of New to The Street. "This show exemplifies our mission to present breakthrough companies and ideas with credibility, scale, and reach."

Media Contact:
Monica Brennan
New to The Street - Media Relations
Monica@NewToTheStreet.com

Watch & Learn More:
www.NewToTheStreet.com
www.IPOMarket.com
www.Arrive.ai
www.Hapbee.com
www.SGTMTech.com
www.BioVie.com
www.floki.com

SOURCE: New to The Street



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/publishing-and-media/new-to-the-street-episode-%23678-to-air-on-bloomberg-tv-featuring-game-changing-1048163

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.